FindTrial
Sign In

LIPID LEVELS IN KIDNEY DISEASE.

A STUDY OF LIPID PROFILE IN CHRONIC KIDNEY DISEASE.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/01/017132
Enrollment
300
Registered
2019-01-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N189- Chronic kidney disease, unspecified

Interventions

None listed

Sponsors

Vishwanath Matur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with chronic kidney disease with established chronic kidney disease irrespective of the etiology. 2.Above the age of 18 years. 3.On conservative treatment and pre dialysis patients and patients who underwent dialysis treatment for chronic kidney disease. 4.As evidenced radiologically or biochemically (elevated blood urea, serum creatinine) for more than 3 months

Exclusion criteria

Exclusion criteria: 1.PREGNANT WOMEN 2.AKI PATIENTS 4.PATIENTS WHO ARE ON LIPID ALTERING AGENTS LIKE B-BLOCKERS,OCPS,THIAZIDES.

Design outcomes

Primary

MeasureTime frame
total cholesterol, HDL-Cholesterol, LDL-Cholesterol and triglyceride levelsTimepoint: 1 WEEK—

Secondary

MeasureTime frame
The spectrum of lipid disorders in chronic kidney disease (CKD) is usually characterized by high triglycerides and reduced high dense lipoprotein (HDL), associated with normal or slightly incread low dense lipoprotein (LDL)-cholesterol.Timepoint: EVERY 6 MONTHS—

Countries

India

Contacts

Public ContactVishwanath Matur

KMC MANIPAL

mm.prabhu@manipal.edu9632118700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026